Status and phase
Conditions
Treatments
About
This trial will be comparing the combination of amiodarone and NAC (n=122) to amiodarone alone and NAC matched placebo (n=122) to determine the rates with which sustained (lasting >30 seconds) or clinically significant POAF is reduced in high risk patients within 7 days after major thoracic surgery.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients ≥18 years old scheduled for elective thoracic surgery (segmentectomy, lobectomy or bi-lobectomy, pneumonectomy or esophagectomy) and meeting one of the four following risk criteria:
Patients in sinus rhythm.
Patients with stable respiratory status (no respiratory distress).
Patients capable of providing written, informed consent.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
184 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal